Advertisement
 

Health

BRIEFLY

January 11, 1995|From Times Staff and Wire Reports

FDA Gives OK for Syphilis, Ovarian Cancer Detection Tests: Centocor Inc. said it has received Food and Drug Administration approval to market the new diagnostic tests. The Malvern, Pa., company said its syphilis test, Captia Syphilis-G, is cleared for use in blood banks and testing laboratories. The test can be used as a primary screening method for certain antibodies in human serum or plasma. Centocor's CA 125 II test will be used as an aid to detect residual epithelial ovarian cancer.

Advertisement
Los Angeles Times Articles
|
|
|